Merck & Co., Inc. (MRK) Tops Q3 EPS by 3c
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $128.66 --0%
Revenue Growth %: +3.5%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Revenue Growth %: +3.5%
Financial Fact:
Research and development: 5.14B
Today's EPS Names:
DTGI, OCCI, MAYS, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q3 EPS of $0.94, $0.03 better than the analyst estimate of $0.91. Revenue for the quarter came in at $12 million versus the consensus estimate of $11.61 billion.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Merck reaches deal to expand HIV drug access via ADAP programs
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
- American Outdoor Brands (AOUT) Tops Q4 EPS by 14c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
